Methods and compositions for controlling hyperparathyroidism are disclosed.

Disclosed herein are methods and compositions useful in reducing inflammation, reducing inflammatory exudates, enhancing epithelial tissue generation or regeneration, and/or reducing mean pulmonary artery pressure in the lungs of a subject in need thereof. In particular, the compositions comprise vitamin D, an analog, or metabolite thereof, and the methods include administering the composition to a subject in need thereof. In some embodiments, the subject is suffering from an infection, such as a viral infection, which affects the lungs. In some embodiments, the viral infection comprises SARS-CoV-2.

Disclosed herein are methods and compositions useful in reducing inflammation, reducing inflammatory exudates, enhancing epithelial tissue generation or regeneration, and/or reducing mean pulmonary artery pressure in the lungs of a subject in need thereof. In particular, the compositions comprise vitamin D, an analog, or metabolite thereof, and the methods include administering the composition to a subject in need thereof. In some embodiments, the subject is suffering from an infection, such as a viral infection, which affects the lungs. In some embodiments, the viral infection comprises SARS-CoV-2.

Provided herein are methods and combination therapies useful for the treatment of non-alcoholic fatty liver diseases (NAFLD). In particular, provided herein are methods and combination therapies for treating NAFLD by administering a combination therapy comprising (a) the compound of Formula (I), or a pharmaceutically acceptable salt thereof, and (b) an antioxidant, or a pharmaceutically acceptable salt thereof. Also provided are pharmaceutical compositions and pharmaceutical combinations comprising the compound of Formula (I), or a pharmaceutically acceptable salt thereof, and an antioxidant, or a pharmaceutically acceptable salt thereof.

Provided herein are methods and combination therapies useful for the treatment of non-alcoholic fatty liver diseases (NAFLD). In particular, provided herein are methods and combination therapies for treating NAFLD by administering a combination therapy comprising (a) the compound of Formula (I), or a pharmaceutically acceptable salt thereof, and (b) an antioxidant, or a pharmaceutically acceptable salt thereof. Also provided are pharmaceutical compositions and pharmaceutical combinations comprising the compound of Formula (I), or a pharmaceutically acceptable salt thereof, and an antioxidant, or a pharmaceutically acceptable salt thereof.

D vitamins enhanced nutraceutical compositions including one or more UV light treated, dried, and comminuted fungus materials and nutraceutical compositions including one or more UV light treated, dried, and comminuted fungus materials and one or more dried and comminuted herb materials and methods for making and using same.

D vitamins enhanced nutraceutical compositions including one or more UV light treated, dried, and comminuted fungus materials and nutraceutical compositions including one or more UV light treated, dried, and comminuted fungus materials and one or more dried and comminuted herb materials and methods for making and using same.

A micronutrient dosage unit which comprises two or more micronutrients selected from vitamin A, vitamin B.sub.2, vitamin B.sub.6, vitamin B.sub.9, vitamin B.sub.12, vitamin C, vitamin D, vitamin E, vitamin K, calcium, magnesium, zinc, boron and chromium in one or more specified ratios.

A micronutrient dosage unit which comprises two or more micronutrients selected from vitamin A, vitamin B.sub.2, vitamin B.sub.6, vitamin B.sub.9, vitamin B.sub.12, vitamin C, vitamin D, vitamin E, vitamin K, calcium, magnesium, zinc, boron and chromium in one or more specified ratios.

A micronutrient dosage unit which comprises two or more micronutrients selected from vitamin A, vitamin B.sub.2, vitamin B.sub.6, vitamin B.sub.9, vitamin B.sub.12, vitamin C, vitamin D, vitamin E, vitamin K, calcium, magnesium, zinc, boron and chromium in one or more specified ratios.